Retinal vascular occlusion in patients infected with human immunodeficiency virus

Retina

Volumn 25, Issue 6, 2005, Pages 759-766

  Dunn, James P ^a,c   Yamashita, Andrea ^a   Kempen, John H ^a   Jabs, Douglas A ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION COMPLICATION; MALE; MULTIPLE REGRESSION; OPTIC NERVE ATROPHY; RETINA DISEASE; RETINOPATHY; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; VASCULAR DISEASE; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE;

ADULT; AGED; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 24344496915     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200509000-00012     Document Type: Review

References (35)

1. Holland GN, Pepose JS, Pettit TH, et al. Acquired immune deficiency syndrome: ocular manifestations. Ophthalmology 1983;90:859-872.
2. Jabs DA. Ocular manifestation in HIV infection. Trans Am Ophthalmol Soc 1995;93:623-683.
3. Freeman WR, Lemer CW, Mores JA, et al. A prospective study of the ophthalmic findings in the acquired immune deficiency syndrome. Am J Ophthalmol 1984;97:133-142.
4. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of acquired immunodeficiency syndrome. Ophthalmology 1989;19:1092-1099.
5. Newsome DA, Green WR, Miller ED, et al. Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol 1986;98:590-601.
6. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immunodeficiency syndrome: pathogenic mechanisms of ocular disease. Ophthalmology 1985;92:472-484.
7. Freeman WR, Chen A, Henderly DE, et al. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol 1989;107:229-235.
8. Engstrom RF, Holland GN, Hardy WD, Meiselmon HJ. Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy. Am J Ophthalmol 1990;109:153-161.
9. Teich SA, Sonnabend J. Central retinal vein occlusion in a patient with AIDS. Arch Ophthalmol 1988;106:1508-1509.
10. Roberts SP, Haefs TMP. Central retinal vein occlusion in middle aged adult with HIV infection. Optom Vis Sci 1992;69:567-569.
11. Ismail Y, Nemechek PM, Asura EL. A rare cause of visual loss in AIDS patients: central retinal vein occlusion. Br J Ophthalmol 1993;77:600-601.
12. Friedman SM, Margo CE. Bilateral central retinal vein occlusions in a patient with acquired immunodeficiency syndrome. Clinicopathologic correlation. Arch Ophthalmol 1995;113:1184-1188.
13. Goldsmith W, Buckner J. Central retinal vein occlusion in an AIDS patient: a case report. South J Optom 1992;10:35-38.
14. Mansour AM, Li H, Segal E. Picture resembling hemicentral retinal vein occlusion in the acquired immunodeficiency syndrome: is it related to cytomegalovirus? Ophthalmologica 1996;210:108-111.
15. Park KL, Marx JL, Rao NA. Noninfectious branch retinal vein occlusion in human immunodeficiency virus-positive patients. Retina 1997;17:162-165.
16. Conway MD, Tong P, Olk RJ. Branch retinal artery occlusion (BRAO) combined with branch retinal vein occlusion (BRVO) and optic disc neovascularization associated with HIV and CMV retinitis. Intern Ophthalmol 1996;19:240-252.
17. Yassur Y, Biedner B, Fabrikant M. Branch retinal-artery occlusion in acquired immunodeficiency syndrome prodrome. Ann Ophthalmol 1988;20:191-195.
18. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for the acquired immune deficiency syndrome among adolescents and adults. Morbid Mortal Wkly Report MMWR 1992;41:2.
19. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000;98:133-141.
20. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996;114:1243-1247.
21. Fong ACO, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol 1993;37:393-417.
22. Cobo-Soriano R, Sanchez-Ramon S, Aparicio MJ, et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol 1999;128:725-732.
23. Graham EM. The investigation of patients with retinal vascular occlusion. Eye 1990;4:464-468.
24. Sanborn GE, Magargal LE, Jaeger EA. Venous occlusive disease of the retina. In: Duane TD, ed. Clinical Ophthalmology. New York: Harper and Row Publishers: 1986:1-19.
25. Sperduto RD, Hiller R, Chew E, et al. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion. Ophthalmology 1998;105:765-771.
26. Larsson I, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996;80:200-203.
27. Abu El-Asrar AM, Abdel Gader AG, Al-Amro S, Al-Momen AK. Hypercoagulable states in patients with retinal venous occlusion. Doc Ophthalmol 1998;95:133-143.
28. Greiner K, Hafner G, Dick B, Peetz D, Prellwitz W, Pfeiffer N. Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 1999;128:69-74.
29. Cassen IH, Tomsak RL, DeLuise VP. Mixed arteriovenous occlusive disease. J Clin Neuroophthalmol 1985;5:164-168.
30. Duker JS, Cohen MS, Brown GC, et al. Combined branch retinal artery and central retinal vein occlusion. Retina 1990;10:105-112.
31. Manogue KR, van Deventer SIH, Cerami A. Tumor necrosis factor alpha or cachectin. In: Thomas A, ed. The Cytokine Handbook. San Diego, CA: Academic Press; 1991:254.
32. Pomerantz RI, Kuritzkes DR, De La Monte SM, et al. Infection of the retina by human immunodeficiency virus type 1. N Engl J Med 1987;317:1643-1647.
33. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DI, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093-2099.
34. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994;117:429-441.
35. Palella F, Delaney K, Moorman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.